Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | November 13, 2023 | November 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date November 13, 2023 · Filed November 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 112,425 |
Reported balance
After 2023-11-13 transaction · row 1
1 source rowRow 1 · 2023-11-13 · Sale · Disposed 25,000 · Balance 112,425 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.1416 to $32.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.1416 to $32.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2023 Filed Nov 14, 2023 16:12 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 25,000 | $32.19 | $804,810.00 |
DisclosureSEC source: 0001628280-23-038941 · wk-form4_1699996318.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,425 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.1416 to $32.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:47 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 4,865 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001628280-23-022494 · wk-form4_1686948441.xml · derivative · entry 2 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 4,865 shares Expires 2033-06-14 F2 · derivative.exercise_date: The Stock Option was granted on June 15, 2023 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:47 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 2,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022494 · wk-form4_1686948441.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,425 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 16:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 2,797 | $37.03 | $103,577.94 |
DisclosureSEC source: 0001628280-23-006551 · wf-form4_167813997415350.xml · nonDerivative · entry 2 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,714 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 8, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.6400 to $37.2700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 16:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 12,203 | $35.94 | $438,580.70 |
DisclosureSEC source: 0001628280-23-006551 · wf-form4_167813997415350.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,511 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 8, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.6300 to $36.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:11 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock · Derivative | 4,205 | $0.00 Strike: $38.85 | $0.00 |
DisclosureSEC source: 0001628280-22-016684 · wf-form4_165480548968471.xml · derivative · entry 2 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,205 Underlying: Common Stock · 4,205 shares Expires 2032-06-06 F2 · price: The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. F2 · derivative.exercise_date: The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:11 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 2,001 | $37.48 | $74,997.48 |
DisclosureSEC source: 0001628280-22-016684 · wf-form4_165480548968471.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,714 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:01 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | PurchaseCommon Stock | 940 | $24.43 | $22,960.63 |
DisclosureSEC source: 0001628280-22-006089 · wf-form4_164729143902376.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,713 Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 18:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | ConversionSeries C Convertible Preferred Stock · Derivative | 21,929 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-018957 · wf-form4_163226372386899.xml · derivative · entry 4 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,929 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 18:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | ConversionSeries B Convertible Preferred Stock · Derivative | 34,230 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-018957 · wf-form4_163226372386899.xml · derivative · entry 3 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,230 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 18:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | PurchaseCommon Stock | 6,800 | $25.00 | $170,000.00 |
DisclosureSEC source: 0001628280-21-018957 · wf-form4_163226372386899.xml · nonDerivative · entry 2 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Morgan Colby Wood Trust Disclosed balance after: 6,800 F2 · shares: Represents a purchase in the Issuer's public offering. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 18:35 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | ConversionCommon Stock | 56,159 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-018957 · wf-form4_163226372386899.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date. Read SEC document |
| September 17, 2021 Filed Sep 22, 2021 21:28 UTC Amendment | PROCEPT BioRobotics Corp PRCT · Entity 4831 | PurchaseCommon Stock | 3,200 | $25.00 | $80,000.00 |
DisclosureSEC source: 0001628280-21-019066 · wf-form4a_163236052125243.xml · nonDerivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,200 F1 · price: Represents a purchase in the Issuer's public offering. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 18:38 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 10,308 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0001628280-21-018793 · wf-form4_163183191299916.xml · derivative · entry 1 Wood Morgan Colby · CIK 0001881573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,308 Underlying: Common Stock · 10,308 shares Expires 2031-09-14 F1 · shares: Option will vest and become exercisable in full on the earlier of September 14, 2022 or the day prior to the date of the 2022 annual meeting of the stockholders, subject to the director's continued service. F1 · price: Option will vest and become exercisable in full on the earlier of September 14, 2022 or the day prior to the date of the 2022 annual meeting of the stockholders, subject to the director's continued service. F1 · derivative.exercise_date: Option will vest and become exercisable in full on the earlier of September 14, 2022 or the day prior to the date of the 2022 annual meeting of the stockholders, subject to the director's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.